Skip to content

KETOMY: trail, Safety, efficacy and feasibility of ketogenic diet in mitochondrial myopathy,

KETOMY: trail, Safety, efficacy and feasibility of ketogenic diet in mitochondrial myopathy, - KETOMY

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON55294
Enrollment
35
Registered
2020-08-26
Start date
2020-10-13
Completion date
Unknown
Last updated
2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

OXPOS deffects resporatoirychain deffects

Interventions

Modified Atkins diet

Sponsors

Radboud Universitair Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: 1. Genetically proven mitochondrial disease 2. Age * 18 years 3. Myopathy: this can be muscle weakness or exercise intolerance. The NMDAS sub score for muscle weakness( NMDAS part III question 5) and/or exercise intolerance (NMDAS part I question 9) of 1 or higher. 4. Good understanding of the Dutch language 5. Able to adhere to the diet for 12 weeks, considering their cognition level and cooking skill 6. Signed informed consent for the healthy controls 1 and 6 + healthy no medication and

Exclusion criteria

Exclusion criteria: 1. Elevated CK levels > 1000 u/l 2. Malnutrition: BMI

Design outcomes

Primary

MeasureTime frame
- Safety Adverse events - Feasibility Number of patients who complete the 12-week intervention - Efficacy VO2max/peak during maximal incremental cycle exercise test Biomarkers by using metabolomic profiling in plasma.

Secondary

MeasureTime frame
Secondary outcomes safety: blood test for: * glucose (for occurrence hypoglycaemia), * lipid profile: (triglycerides, high-density lipoprotein (HDL), low-density lipoprotein (LDL), total cholesterol), * Uric acid * ALAT * blood gas (including Bi-carbonate, lactate, glucose, natrium and potassium) Secondary outcomes:Feasibility * Number of patients who manage to reach ketone body levels of *2 * Reason of drop out * Carbohydrate intake in food record as a variable for diet adherence * Questions on the feasibility of the diet. Secondary outcomes:Efficacy * Muscle contractile function * Fatigue: CIS fatigue * Quality of life: SF 12 * Headache: diary * Questions on the benefits of the diet. * Activity and energy expendure: Actometer (METS)

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)